Caris Life Sciences, INC Schedule 13G passive stakes

J.H. Whitney VI, L.P. and associated entities have updated their Schedule 13G filing, reporting a 4.0% beneficial ownership in Caris Life Sciences, Inc.

TSSP Sub-Fund HoldCo, LLC and Alan Waxman have filed an exit statement, indicating they no longer beneficially own more than five percent of Caris Life Sciences' common stock.

J.H. Whitney VI, L.P. and affiliated entities report beneficial ownership of 18,256,615 shares, representing 6.5% of Caris Life Sciences' common stock.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10.8% in Caris Life Sciences Inc. as of March 31, 2026.

FMR LLC and Abigail P. Johnson have reported a 5.0% beneficial ownership stake in Caris Life Sciences Inc. common stock.

A group led by J.H. Whitney VI L.P. has reported beneficial ownership of 7.3% of Caris Life Sciences, Inc.'s common stock.

David D. Halbert and Caris Halbert, L.P. disclose significant beneficial ownership, collectively holding 44.1% of Caris Life Sciences, Inc. common stock.

TSSP Sub-Fund HoldCo, LLC and Alan Waxman have jointly disclosed beneficial ownership of 8.3% and 8.8% respectively, of Caris Life Sciences, Inc.'s Common Stock as of June 30, 2025.

Millennium Management LLC and affiliated entities have filed a Schedule 13G, disclosing a beneficial ownership of 1.3% in Caris Life Sciences, Inc., after previously exceeding the 5% threshold.